Please login to the form below

Not currently logged in
Email:
Password:

PRISM

This page shows the latest PRISM news and features for those working in and with pharma, biotech and healthcare.

EU nod for BioMarin’s second PKU therapy Palynziq

EU nod for BioMarin’s second PKU therapy Palynziq

The Palynziq approval was based on data from an eight-week phase 3 pivotal study, PRISM-2 and an ongoing open label extension study at 36 months.

Latest news

More from news
Approximately 0 fully matching, plus 13 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Egalet appoints Stan Musial as CFO Egalet appoints Stan Musial as CFO

    His most recent in-house role was as chief financial officer at Prism Pharmaceuticals, where he served from 2005 to 2011 before its sale to Baxter Healthcare. ... Prior to joining Prism, Musial held the position of VP, finance, and chief financial

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Use digital to maximise the value of sales meetings

    Smartphones. In the same way, applying the prism of added value to the prolific use of smartphones helps generate the following strategically-helpful questions: How can smartphone use enhance a reason

  • Prism Ideas Prism Ideas

    Prism Ideas represents the highest standards in scientific service provision for the pharmaceutical industry in the areas of drug and diagnostic development and medical communications.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....